
NuCana plc NCNA
€ 0.75
-7.87%
Land |
|
IPO-Jahr |
2017 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
11.2 B |
Marktkapitalisierung |
$ 9.21 B |
EBITDA (LTM) |
$ -20.1 M |
P/E (LTM) |
-3.615385 |
P/S (LTM) |
- |
EPS (LTM) |
-0.26 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Galectin Therapeutics
GALT
|
$ 3.0 | 2.92 % | $ 192 M | Nasdaq Global Select Market | ||
|
Processa Pharmaceuticals
PCSA
|
$ 1.7 | -2.3 % | $ 2.23 M | Nasdaq Global Select Market | ||
|
Corcept Therapeutics Incorporated
CORT
|
$ 67.94 | -3.04 % | $ 7.06 B | Nasdaq Capital Market,SPB | ||
|
Progenity, Inc.
PROG
|
- | -3.47 % | $ 164 M | Nasdaq Global Select Market | ||
|
China SXT Pharmaceuticals
SXTC
|
$ 2.84 | -0.7 % | $ 1.93 M | Nasdaq Global Select Market | ||
|
Genprex
GNPX
|
$ 1.73 | 3.56 % | $ 1.61 M | Nasdaq Capital Market | ||
|
Strongbridge Biopharma plc
SBBP
|
- | 1.52 % | $ 136 M | Nasdaq Global Select Market | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
$ 21.27 | -1.71 % | $ 33.6 B | NYSE | ||
|
Protara Therapeutics
TARA
|
$ 2.33 | 0.22 % | $ 99.8 M | Nasdaq Global Market | ||
|
Innate Pharma S.A.
IPHA
|
$ 1.0 | -24.81 % | $ 89.6 M | Nasdaq Global Select Market | ||
|
Seneca Biopharma, Inc.
SNCA
|
- | -1.19 % | $ 28.7 M | Nasdaq Capital Market | ||
|
BioMarin Pharmaceutical
BMRN
|
$ 61.57 | 5.22 % | $ 11.8 B | Nasdaq Global Select Market,SPB | ||
|
Bio-Techne Corporation
TECH
|
$ 72.74 | 0.15 % | $ 11.3 B | Nasdaq Global Select Market,SPB | ||
|
Matinas BioPharma Holdings
MTNB
|
$ 0.91 | 6.35 % | $ 4.98 M | NYSE American | ||
|
Enanta Pharmaceuticals
ENTA
|
$ 8.21 | -5.52 % | $ 175 K | Nasdaq Global Select Market,SPB | ||
|
Milestone Pharmaceuticals
MIST
|
$ 0.46 | 10.45 % | $ 48.9 M | Nasdaq Global Select Market | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
$ 42.18 | -1.04 % | $ 48.3 B | NYSE | ||
|
Scholar Rock Holding Corporation
SRRK
|
$ 47.99 | 6.46 % | $ 5.5 B | Nasdaq Global Select Market | ||
|
Lipocine
LPCN
|
$ 1.54 | -3.75 % | $ 8.39 M | Nasdaq Global Select Market | ||
|
Seres Therapeutics
MCRB
|
$ 1.45 | 2.48 % | $ 12.8 M | Nasdaq Global Select Market | ||
|
Madrigal Pharmaceuticals
MDGL
|
$ 398.15 | -5.65 % | $ 8.93 B | Nasdaq Global Select Market,SPB | ||
|
CEL-SCI Corporation
CVM
|
$ 1.38 | -25.41 % | $ 11.1 M | NYSE American,SPB | ||
|
Inventiva S.A.
IVA
|
$ 3.4 | 5.43 % | $ 203 M | Nasdaq Global Market | ||
|
MeiraGTx Holdings plc
MGTX
|
$ 8.3 | -1.89 % | $ 668 M | Nasdaq Global Select Market | ||
|
Trevi Therapeutics
TRVI
|
$ 13.55 | 0.26 % | $ 1.83 B | Nasdaq Global Market | ||
|
Eton Pharmaceuticals
ETON
|
$ 62.05 | -2.51 % | $ 1.67 B | Nasdaq Global Market | ||
|
IDEAYA Biosciences
IDYA
|
$ 26.13 | -4.64 % | $ 2.31 B | Nasdaq Global Select Market | ||
|
Protalix BioTherapeutics
PLX
|
$ 2.96 | 1.9 % | $ 232 M | NYSE American | ||
|
Lantern Pharma
LTRN
|
$ 0.33 | -10.93 % | $ 3.6 M | Nasdaq Global Select Market | ||
|
Foghorn Therapeutics
FHTX
|
$ 1.8 | -1.91 % | $ 113 M | Nasdaq Global Market | ||
|
Ocugen
OCGN
|
$ 0.73 | -2.88 % | $ 228 M | Nasdaq Capital Market | ||
|
Oncolytics Biotech
ONCY
|
$ 0.44 | 15.71 % | $ 42.2 M | Nasdaq Global Select Market | ||
|
Minerva Neurosciences
NERV
|
$ 2.18 | 0.93 % | $ 18.5 M | Nasdaq Global Market | ||
|
Kamada Ltd.
KMDA
|
$ 8.07 | -1.04 % | $ 465 M | Nasdaq Global Select Market | ||
|
Neurocrine Biosciences
NBIX
|
$ 162.75 | -1.91 % | $ 16.2 B | Nasdaq Global Select Market,SPB | ||
|
Nanobiotix S.A.
NBTX
|
$ 26.8 | -2.37 % | $ 1.28 T | Nasdaq Global Select Market | ||
|
Mereo BioPharma Group plc
MREO
|
$ 0.29 | 5.5 % | $ 231 M | Nasdaq Global Select Market | ||
|
Maravai LifeSciences Holdings
MRVI
|
$ 7.38 | 0.27 % | $ 1.07 B | Nasdaq Global Select Market | ||
|
Lexicon Pharmaceuticals
LXRX
|
$ 1.73 | -2.81 % | $ 628 M | Nasdaq Global Select Market | ||
|
Moleculin Biotech
MBRX
|
$ 6.86 | 0.44 % | $ 8.13 M | Nasdaq Global Select Market | ||
|
Arcus Biosciences
RCUS
|
$ 15.76 | -3.84 % | $ 1.69 B | NYSE,SPB | ||
|
Nurix Therapeutics
NRIX
|
$ 14.11 | -0.95 % | $ 1.22 B | Nasdaq Global Select Market,SPB | ||
|
Nkarta
NKTX
|
$ 1.2 | -4.4 % | $ 88.8 M | Nasdaq Global Select Market | ||
|
MacroGenics
MGNX
|
$ 1.98 | -3.66 % | $ 125 M | Nasdaq Global Select Market | ||
|
Protagonist Therapeutics
PTGX
|
$ 127.33 | 1.65 % | $ 8.09 B | Nasdaq Global Select Market | ||
|
Novo Nordisk A/S
NVO
|
$ 39.46 | -3.05 % | $ 175 B | NYSE | ||
|
Marker Therapeutics
MRKR
|
$ 0.83 | -0.23 % | $ 12.7 M | Nasdaq Global Market | ||
|
Replimune Group
REPL
|
$ 19.81 | 0.61 % | $ 1.84 B | Nasdaq Global Select Market | ||
|
NextCure
NXTC
|
$ 6.87 | 2.54 % | $ 36.5 M | Nasdaq Global Select Market | ||
|
Rocket Pharmaceuticals
RCKT
|
$ 2.13 | 1.18 % | $ 237 M | Nasdaq Global Select Market |